Democrats’ presidential hopeful backs embryo stem cell research
Senator John Kerry, the Democrats’ all-but-endorsed candidate for president, says that he would overturn George W. Bush’s ban on expanding federal funding for research on embryonic stem cells.
Recalling that heart transplants had once been ethically contentious, Senator Kerry said, “the medical discoveries that come form stem cells are crucial next steps in humanity’s uphill climb…
Part of this nation’s greatness lies in the fact that we have led the world in great medical discoveries, with our breakthroughs and our beliefs going hand in hand.” However, despite pressure from Congress, various lobby groups and former first lady Nancy Reagan, President Bush dug his heels in this week on the issue of stem cells. “The president doesn’t believe we should be creating life for the sole purpose of destroying life,” said the White House spokesman.
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...